Genotoxic effects of drospirenone and ethinylestradiol in human breast cells (in vitro) and bone marrow cells of female mice (in vivo)

References

• Ali, E.H., 2008. Protective effects of Echinacea on cyproterone acetate induced liver damage in male rats. Pakistan Journal of Biological Sciences : PJBS, 11 (21), 2464–2471.
   PubMedGoogle Scholar
• Al-Juraisy, Y.H., 2016. Modulatory effects of date palm (Phoenix dactylifera l.) pits extract against ethinylestradiol induced genotoxic damage in cultured human lymphocytes. Iraqi Journal of Science, 57, 576–582.
   Google Scholar
• Anderson, E., 2002. The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Research : BCR, 4 (5), 197–201.
   PubMed Web of Science ®Google Scholar
• Azqueta, A. and Collins, A.R., 2013. The essential comet assay: a comprehensive guide to measuring DNA damage and repair. Archives of Toxicology, 87 (6), 949–968.
   PubMed Web of Science ®Google Scholar
• Bellanti, F., et al., 2013. Sex hormones modulate circulating antioxidant enzymes: impact of estrogen therapy. Redox Biology, 1 (1), 340–346.
   PubMed Web of Science ®Google Scholar
• Blode, H., et al., 2012. Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women. The European Journal of Contraception & Reproductive Health Care : The Official Journal of the European Society of Contraception, 17 (4), 284–297.
   PubMed Web of Science ®Google Scholar
• Brambilla, G. and Martelli, A., 2004. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens. Toxicology, 196 (1-2), 1–19.
   PubMed Web of Science ®Google Scholar
• Brisken, C., 2013. Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. Nature Reviews. Cancer, 13 (6), 385–396.
   PubMed Web of Science ®Google Scholar
• Burcham, P.C., 1998. Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts. Mutagenesis, 13 (3), 287–305.
   PubMed Web of Science ®Google Scholar
• Capel, I.D. and Smallwood, A.E., 1983. Sex differences in the glutathione peroxidase activity of various tissues of the rat. Research Communications in Chemical Pathology and Pharmacology, 40 (3), 367–378.
   PubMedGoogle Scholar
• Cavalieri, E., et al., 2000. Estrogens as endogenous genotoxic agents—DNA adducts and mutations. JNCI Monographs, 2000 (27), 75–93.
   Google Scholar
• Cavalieri, E. and Rogan, E., 2014. The molecular etiology and prevention of estrogen-initiated cancers: Ockham’s Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity. Molecular Aspects of Medicine, 36, 1–55.
   PubMed Web of Science ®Google Scholar
• Chlebowski, R.T., et al., 2013. Estrogen plus progestin and breast cancer incidence and mortality in the women’s health initiative observational study. JNCI: Journal of the National Cancer Institute, 105 (8), 526–535.
   PubMedGoogle Scholar
• Daradka, H.M. and Alshibly, N.M.Y., 2012. Effect of Artemisia alba L. extract against ethinylestradiol induced genotoxic damage in cultured human lymphocytes. African Journal of Biotechnology, 11 (86), 15246–15250.
   Google Scholar
• Fernandez, S.V. and Russo, J., 2010. Estrogen and xenoestrogens in breast cancer. Toxicologic Pathology, 38 (1), 110–122.
   PubMed Web of Science ®Google Scholar
• Grujičić, D., et al., 2016. Cytogenetic biomarkers in detection of genotoxic effects of gestagens in peripheral blood lymphocytes in vitro and in vivo. European Journal of Medical Genetics, 59 (12), 624–633.
   PubMed Web of Science ®Google Scholar
• Hilton, H.N., et al., 2015. Minireview: progesterone regulation of proliferation in the normal human breast and in breast cancer: a tale of two scenarios? Molecular Endocrinology (Baltimore, Md.), 29 (9), 1230–1242.
   PubMed Web of Science ®Google Scholar
• Hilton, H.N., et al., 2014. Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. Oncotarget, 5 (18), 8651–8664.
   PubMedGoogle Scholar
• Hunter, D.J., et al., 2010. Oral contraceptive use and breast cancer: a prospective study of young women. Cancer Epidemiology Biomarkers & Prevention, 19 (10), 2496–2502.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer (IARC), 2012. Monographs on the evaluation of carcinogenic risks to humans, hormonal contraception and post-menopausal hormonal therapy, Vols. 72, 91, 100A. Lyon, France: IARC.
   Google Scholar
• International Agency for Research on Cancer, 1987. IARC monographs on the evaluation of the carcinogenic risks to humans, supplement 7: overall evaluations of carcinogenicity: an updating of IARC monographs. Vols. 1–42. Lyon, France: IARC, 96–97, 273–310.
   Google Scholar
• Johnson, T.M., et al., 1996. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 93 (21), 11848–11852.
   PubMed Web of Science ®Google Scholar
• Kawai, Y. and Nuka, E., 2018. Abundance of DNA adducts of 4-oxo-2-alkenals, lipid peroxidation-derived highly reactive genotoxins. Journal of Clinical Biochemistry and Nutrition, 62 (1), 3–10.
   PubMed Web of Science ®Google Scholar
• Kerdar, R.S., et al., 1995. Identification of 3 alpha-hydroxy-cyproterone acetate as a metabolite of cyproterone acetate in the bile of female rats and the potential of this and other already known or putative metabolites to form DNA adducts in vitro. Carcinogenesis, 16 (8), 1835–1841.
   PubMed Web of Science ®Google Scholar
• Kowalska, K. and Milnerowicz, H., 2016. Pro/antioxidant status in young healthy women using oral contraceptives. Environmental Toxicology and Pharmacology, 43, 1–6.
   PubMed Web of Science ®Google Scholar
• Krattenmacher, R., 2000. Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception, 62 (1), 29–38.
   PubMed Web of Science ®Google Scholar
• Lang, R. and Redmann, U., 1979. Non-mutagenicity of some sex hormones in the Ames Salmonella microsome mutagenicity test. Mutation Research, 67 (4), 361–365.
   PubMed Web of Science ®Google Scholar
• Lang, R. and Reimann, R., 1993. Studies for a genotoxic potential of some endogenous and exogenous sex steroids. I. Communication: examination for the induction of gene mutations using the Ames Salmonella/microsome test and the HGPRT test in V79 cells. Environmental and Molecular Mutagenesis, 21 (3), 272–304.
   PubMed Web of Science ®Google Scholar
• Liao, W., et al., 2009. The comet assay: a sensitive method for detecting DNA damage in individual cells. Methods (San Diego, Calif.), 48 (1), 46–53.
   PubMed Web of Science ®Google Scholar
• Liehr, J.G., 1997. Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters. Environmental Health Perspective, 105 (3), 565–569.
   PubMed Web of Science ®Google Scholar
• Lieselot, Y., et al., 2016. Diet-related DNA adduct formation in relation to carcinogenesis. Nutrition Reviews, 74, 475–489.
   PubMed Web of Science ®Google Scholar
• Lovett, J.L., et al., 2017. Oral contraceptives cause evolutionarily novel increases in hormone exposure: a risk factor for breast cancer. Evolution, Medicine, and Public Health, 2017 (1), 97–108.
   PubMed Web of Science ®Google Scholar
• Lydon, J.P., et al., 1999. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Research, 59 (17), 4276–4284.
   PubMed Web of Science ®Google Scholar
• Marnett, L.J., 1999. Lipid peroxidation – DNA damage by malondialdehyde. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 424 (1-2), 83–95.
   PubMed Web of Science ®Google Scholar
• Marnett, L.J., 2002. Oxyradicals, lipid peroxidation and DNA damage. Toxicology, 181-182, 219–222.
   PubMed Web of Science ®Google Scholar
• Marnett, L.J., et al., 2003. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. The Journal of Clinical Investigation, 111 (5), 583–593.
   PubMed Web of Science ®Google Scholar
• Martelli, A., et al., 2003. Species, sex and inter-individual differences in DNA repair induced by nine sex steroids in primary cultures of rat and human hepatocytes. Mutation Research, 536 (1-2), 69–78.
   PubMed Web of Science ®Google Scholar
• Masengu, C., et al., 2014. Inhibitory activity of Combretumzeyheri and its S9 metabolites against Escherchia coli, Bacilus subtulis, and Candida albicans. Journal of Microbiology and Biochemical Technology, 6 (4), 228–235.
   Google Scholar
• Nair, U., et al., 2007. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radical Biology & Medicine, 43 (8), 1109–1120.
   PubMed Web of Science ®Google Scholar
• Nutter, M., et al., 1994. An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage . Chemical Research in Toxicology, 7 (1), 23–28.
   PubMed Web of Science ®Google Scholar
• Orozco-Hernández, L., et al., 2018. 17β-Estradiol induces cyto-genotoxicity on blood cells of common carp (Cyprinus carpio). Chemosphere, 191, 118–127.
   PubMed Web of Science ®Google Scholar
• Osman, A.G., 2014. Genotoxicity tests and their contributions in aquatic environmental research. Journal of Environmental Protection, 05 (14), 1391–1399.
   Google Scholar
• Pajovic, S.B. and Saicic, Z.S., 2008. Modulation of antioxidant enzyme activities by sexual steroid hormones. Physiological Research, 57 (6), 801–811.
   PubMed Web of Science ®Google Scholar
• Poirier, M.C., 2004. Chemical-induced DNA damage and human cancer risk. Nature Reviews. Cancer, 4 (8), 630–637.
   PubMed Web of Science ®Google Scholar
• Reimann, R., Kalweit, S., and Lang, R., 1996. Studies for a genotoxic potential of some endogenous and exogenous sex steroids. II. Communication: examination for the induction of cytogenetic damage using the chromosomal aberration assay on human lymphocytes in vitro and the mouse bone marrow micronucleus test in vivo. Environmental and Molecular Mutagenesis, 28 (2), 133–144.
   PubMed Web of Science ®Google Scholar
• Russo, J. and Russo, I.H., 2006. The role of estrogen in the initiation of breast cancer. The Journal of Steroid Biochemistry and Molecular Biology, 102 (1-5), 89–96.
   PubMed Web of Science ®Google Scholar
• Schulte-Hermann, R., et al., 1981. Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin. Cancer Research, 41, 2256–2262.
   Web of Science ®Google Scholar
• Schulte-Hermann, R., et al., 1988. Quantitative structure-activity studies on effects of sixteen different steroids on growth and monooxygenases of rat liver. Cancer Research, 48, 2462–2468.
   PubMed Web of Science ®Google Scholar
• Siddique, Y.H., et al., 2005. Genotoxic potential of ethinylestradiol in cultured mammalian cells. Chemico-Biological Interactions, 151 (2), 133–141.
   PubMed Web of Science ®Google Scholar
• Siddque, Y.H., et al., 2011. Protective role of Eclipta alba L. extract against ethinylestradiol induced genotoxic damage in cultured human lymphocytes. Alternative Medicine Studies, 1, e4.
   Google Scholar
• Singh, N.P., et al., 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research, 175 (1), 184–191.
   PubMed Web of Science ®Google Scholar
• Stack, D.E., et al., 1996. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chemical Research in Toxicology, 9 (5), 851–859.
   PubMed Web of Science ®Google Scholar
• Stiborová, M., 2018. Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats. Toxicology, 400–401, 48–56.
   PubMed Web of Science ®Google Scholar
• Topinka, J., et al., 1993. Cyproterone acetate generates DNA adducts in rat liver and in primary rat hepatocyte cultures. Carcinogenesis, 14 (3), 423–427.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2005. Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Guidance for Industry. Available from: http://www.fda.gov/cder/guidance/index.htm
   Google Scholar
• Wang, H.-C. and Lee, W.-S., 2016. Molecular mechanisms underlying progesterone-enhanced breast cancer cell migration. Scientific Reports, 6, 31509.
   PubMed Web of Science ®Google Scholar
• Werner, S., et al., 1997. Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes. Mutation Research, 395 (2-3), 179–189.
   PubMed Web of Science ®Google Scholar
• Yager, J.D. and Liehr, J.G., 1996. Molecular mechanisms of estrogen carcinogenesis. Annual Review of Pharmacology and Toxicology, 36, 203–232.
   PubMed Web of Science ®Google Scholar
• Yu, H.-S., et al., 2010. Formation of acetaldehyde-derived DNA adducts due to alcohol exposure. Chemico-Biological Interactions, 188 (3), 367–375.
   PubMed Web of Science ®Google Scholar
• Zhu, B.T. and Conney, A.H., 1998. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis, 19 (1), 1–27.
   PubMed Web of Science ®Google Scholar